Posts classified under: Neurology

Beate Ritz, M.D., Ph.D.

Biography

Beate Ritz joined the faculty of the School of Public Health at UCLA in 1995 and is currently Professor and Vice Chair of the Epidemiology Department and holds co-appointments in the Environmental Health department at the UCLA School of Public Health and in Neurology, UCLA School of Medicine; she is a member of the Center for Occupational and Environmental Health (COEH), the Southern California Environmental Health Science Center (SCEHSC), and co-directs the NIEHS-funded UCLA Center for Gene-Environment Studies of Parkinson’s disease.

Dr. Ritz received her MD and a PhD in Medical Sociology from the University of Hamburg Germany in 1983 and 1987; she was a research fellow and resident at the Psychiatric University-Hospital in Hamburg from 1987-1989, and received doctoral training and a PhD degree in Epidemiology in 1995 from UCLA.

Her research focuses on the health effects of occupational and environmental toxins such as pesticides, ionizing radiation, and air pollution on chronic diseases including neurodegenerative disorders (Parkinson’s disease), cancers, and adverse birth outcomes and asthma. She previously investigated the causes of cancer in chemical toxin and radiation exposed workers and assessed the impact of ergonomic work-place factors on musculo-skeletal disorders. For the past decade, she studied the effects of air pollution on adverse birth outcomes as well as asthma in children in Southern California. In 2006, she received the Robert M Zweig Memorial award for outstanding achievement in air quality and medicine from the South Coast Air Quality Management District. She also spend the past 15 years investigating the long-term effects of pesticide exposures on Parkinson’s disease and cancers and is currently conducting a project to implement a Parkinson’s disease registry required by a new law in California.

In her research she uses geographic information system (GIS) modeling of environmental exposures including pesticide use and traffic related air pollution in California and investigates links between genetic susceptibility factors and environmental exposures in populations. She is directing and collaborating in a large number of federally (NIH, DOD), state (California Air Resources Board), and foundation (Michael J Fox Foundation) funded research projects.

Publications

A selected list of publications:

Manthripragada A, Cockburn M, Costello S, Bronstein J, Ritz B.   Paraoxonase-1 gene Leu-Met 55 polymorphism may modify the estimated effects of agricultural organophosphate exposure on Parkinson’s disease. In Press: Epidemiology, , 2009; .
Ritz–Publications PD Gatto N   Cockburn M, Bronstein J, Ritz B. Well Water Consumption and Parkinson’s Disease in Rural California. , In Press EHP , 2009; .
Costello Sadie, Cockburn Myles, Bronstein Jeff, Zhang Xinbo, Ritz Beate   Parkinson’s disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California American journal of epidemiology, 2009; 169(8): 919-26.
Rhodes Shannon L, Ritz Beate   Genetics of iron regulation and the possible role of iron in Parkinson’s disease Neurobiology of disease, 2008; 32(2): 183-95.
Ritz B, Rull R   Assessment of Environmental Exposures from Agricultural Pesticides in Childhood Leukemia Studies: Challenges and Opportunities, In Press: Radiation Protection Dosimetry, 2008; .
Rhodes SL, Ritz B   Genetics of Iron Regulation and the Possible Role of Iron in Parkinson’s Disease, In Press: Neurobiology of Disease, 2008; .
Rugbjerg K, Ritz B, Korbo L, Martinussen N, Olsen JH   Risk for Parkinson’s Disease After Hospitalization for a Head Injury: A Population-Based Case-Control Study, In Press: BMJ, 2008; .
Wahner AD, Bronstein JF, Bordelon YM, Ritz B   Statin Use and the Risk of Parkinson’s Disease, Neurology, 2008; 70(16 pt. 2): 1418-22.
Wahner Angelika D, Bronstein Jeff M, Bordelon Yvette M, Ritz Beate   Statin use and the risk of Parkinson disease Neurology, 2008; 70(16 Pt 2): 1418-22.
Goldberg Daniel W, Wilson John P, Knoblock Craig A, Ritz Beate, Cockburn Myles G   An effective and efficient approach for manually improving geocoded data International journal of health geographics, 2008; 7(2): 60.
Rugbjerg Kathrine, Ritz Beate, Korbo Lise, Martinussen Nick, Olsen Jørgen H   Risk of Parkinson’s disease after hospital contact for head injury: population based case-control study BMJ (Clinical research ed.), 2008; 337(2): a2494.
Krishnadasan A, Kennedy N, Zhao Y, Morgenstern H, Ritz B   Nested Case-Control Study of Occupational Physical Activity and Prostate Cancer Among Workers Using a Job Exposure Matrix, Cancer Causes Control, 2008; 1: 107-14.
Ritz B, Wilhelm M, Hoggatt KJ, Ghosh JKC   Ambient Air Pollution and Preterm Birth in the UCLA Environment and Pregnancy Outcomes Study, American journal of industrial medicine, 2007; 166(9): 1045-52.
Wahner Angelika D, Bronstein Jeff M, Bordelon Yvette M, Ritz Beate   Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease Neurology, 2007; 69(19): 1836-42.
Ritz Beate, Ascherio Alberto, Checkoway Harvey, Marder Karen S, Nelson Lorene M, Rocca Walter A, Ross G Webster, Strickland Daniel, Van Den Eeden Stephen K, Gorell Jay   Pooled analysis of tobacco use and risk of Parkinson disease Archives of neurology, 2007; 64(7): 990-7.
Rempel DM, Wang PC, Janowitz I, Harrison RJ, Yu F, Ritz B   A Randomized Controlled Trial Evaluating the Effects of New Task Chairs on Shoulder and Neck Pain Among Sewing Machine Operators: The Los Angeles Garment Study, Spine, 2007; 32(9): 931-38.
Karr C, Lumley T, Shepherd K, Davis R, Larson T, Ritz B, Kaufman J   Effect of Subchronic and Chronic Exposure to Ambient Air Pollutants on Infant Bronchiolitis, Am J Epidemiol, 2007; 165(5): 553-60.
Lewis C, Suffet HI, Hoggatt KJ, Ritz B   Estimated Effects of Disinfection By-Products on Preterm Birth in a Population Served by a Single Water Utility, Environmental Health Perspectives, 2007; 115(2): 290-5.
Wahner AD, Glatt CE, Bronstein JF, Ritz B.   Glutathione S-Transferase Mu, Omega, Pi, And Theta Class Variants And Smoking In Parkinson’s Disease. Neurosci Lett. 2007 Feb 21;413(3):274-8, , 2007; .
Wahner AD, Glatt CE, Bronstein JF, Ritz B   Glutathione S-Transferase Mu, Omega, Pi, and Theta Class Variants and Smoking in Parkinson’s Disease, Neurosci Lett. Perspect, 2007; 413(3): 274-8.
Wahner AD, Sinsheimer JS, Bronstein JF, Ritz B   Inflammatory Cytokine Gene Polymorphisms Increase Risk of Parkinson’s Disease, Arch Neurol, 2007; 64(6): 836-40.
Krishnadasan A, Kennedy N, Zhao Y, Morgenstern H, Ritz B   Nested Case- Control Study of Occupational Chemical Exposures and Prostate Cancer in Aerospace and Radiation Worker, American Journal of Industrial Medicine, 2007; 50(5): 383-90.
Wahner AD, Bronstein JF, Bordelon YM, Ritz B   Nonsteroidal Anti-Inflammatory Drugs May Protect Against Parkinson’s Disease, Neurology, 2007; 69(19): 1836-42.
Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, Ross GW, Strickland D, Van Den Eeden SK, Gorell J   Pooled Analysis of Tobacco Use and Risk of Parkinson’s Disease, Archives of Neurology, 2007; 64(7): 990-7.
Mengy YY, Wilhelm M, Rull R, English P, Ritz B   Traffic and Outdoor Air Pollution Levels Near REsidences and Poorly-Controlled Asthma in Adults, Ann Asthma, Allergy, Immunol, 2007; 98(5): 455-63.
Wahner Angelika D, Sinsheimer Janet S, Bronstein Jeff M, Ritz Beate   Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease Archives of neurology, 2007; 64(6): 836-40.
Wang PC, Rempel D, Harrison R, Chan J, Ritz B   Work-Organizational and Personal Factors Associated with Upper Body Musculoskeletal Disorders Among Sewing Machine Operators Occupational Environmental Medicine, 2007; .
Elbaz Alexis, Nelson Lorene M, Payami Haydeh, Ioannidis John P A, Fiske Brian K, Annesi Grazia, Carmine Belin Andrea, Factor Stewart A, Ferrarese Carlo, Hadjigeorgiou Georgios M, Higgins Donald S, Kawakami Hideshi, Krüger Rejko, Marder Karen S, Mayeux Richard P, Mellick George D, Nutt John G, Ritz Beate, Samii Ali, Tanner Caroline M, Van Broeckhoven Christine, Van Den Eeden Stephen K, Wirdefeldt Karin, Zabetian Cyrus P, Dehem Marie, Montimurro Jennifer S, Southwick Audrey, Myers Richard M, Trikalinos Thomas A   Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson’s disease: a large-scale international study Lancet neurology, 2006; 5(11): 917-23.
Ritz Beate, Costello Sadie   Geographic model and biomarker-derived measures of pesticide exposure and Parkinson’s disease Annals of the New York Academy of Sciences, 2006; 1076(11): 378-87.
Ritz B, Zhao Y, Krishnadasan A, Kennedy N, Morgenstern H   Estimated Effects of Hydrazine Exposure on Cancer Incidence and Mortality in Aerospace Workers, Epidemiology, 2006; 17(2): 154-61.
Ritz B, Costello S   Geographic Model and Biomarker-Derived Measures of Pesticide Exposure and Parkinson’s Disease, Ann NY Academy Sci, 2006; 1076: 378-87.
Elbaz A, Nelson LM, Ritz B, et al   Lack of Replication of Thirteen Single-Nucleotide Polymorphisms Implicated in Parkinson’s Disease: A Large-Scale International Study, Lancet Neurol, 2006; 5(11): 917-23.
Schernhammer Eva, Chen Honglei, Ritz Beate   Circulating melatonin levels: possible link between Parkinson’s disease and cancer risk? Cancer causes & control : CCC, 2006; 17(4): 577-82.
Glatt Charles E, Wahner Angelika D, White Daniel J, Ruiz-Linares Andres, Ritz Beate   Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women Human molecular genetics, 2006; 15(2): 299-305.
Kang Gail A, Bronstein Jeff M, Masterman Donna L, Redelings Matthew, Crum Jarrod A, Ritz Beate   Clinical characteristics in early Parkinson’s disease in a central California population-based study Movement disorders : official journal of the Movement Disorder Society, 2005; 20(9): 1133-42.
Ritz B, Tager I, Balmes J   Can Lessons from Public Health Disease Surveillance be Applied to Environmental Public Health Tracking?, Environmental Health Perspectives, 2005; 113(3): 243-9.
Rull Ru, Ritz B   Historical Pesticide Exposure in California Using Pesticide Use Reports and Land-Use Surveys: An Assessment of Misclassification Error and Bias, Environmental Health Perspectives, 2003; 111(13): 1582-9.
Wilhelm M, Ritz B   Residential Proximity to Traffic and Adverse Birth Outcomes in Los Angeles County, California, 1994-1996, Environmental Health Perspectives, 2003; 111(2): 207-16.
Ritz B, Yu F, Chapa G, Fruin S, Shaw G, Harris J   Ambient Air Pollution and Birth Defects, Am J Epidemiol, 2002; 155: 17-25.
Jacob B, Ritz B, Gehring U, Koch A, Bischof W, Wichmann HE, Heinrich J for the INGA-Study group   Indoor Exposure to Molds and Allergic Sensitization, Environmental Health Perspectives, 2002; 110(7): 647-53.
Morgenstern H, Ritz B   Effects of Low-Level Ionizing Radiation and Chemical Exposures on Cancer Mortality in Nuclear and Aerospace Workers: Findings from the UCLA Rocketdyne Study, Occupational Medicine, 2001; 16(2): 219-37.
Ritz B, Yu F, Chapa G, Fruin S   Effect of Air Pollution on Preterm Birth Among Children Born in Southern California Between 1989 and 1993, Epidemiology, 2000; 11: 502-11.
Ritz B, Yu F   Parkinson’s Disease Mortality And Pesticide Exposure in California 1984-1994, International Journal of Epidemiology, 2000; 29: 323-9.
Ritz B, Yu F.   Parkinson’s Disease Mortality And Pesticide Exposure In California 1984 1994. International Journal of Epidemiology, 2000, Vol. 29:323-329, , 2000; .
Ritz B, Morgenstern H, Crawford-Brown D, Young B   The Effects of Internal Radiation Exposure on Cancer Mortality in Nuclear Workers at Rocketdyne/Atomics International, Environmental Health Perspectives, 2000; 108: 743-51.

Bruce Teter, Ph.D.

Publications

A selected list of publications:

Teter Bruce, LaDu Mary Jo, Sullivan Patrick M, Frautschy Sally A, Cole Greg M   Apolipoprotein E isotype-dependent modulation of microRNA-146a in plasma and brain Neuroreport, 2016; 27(11): 791-5.
Teter, B.   Life-span influences of apoE4 on CNS function. Invited Peer Commentary on: Schonheit, B., Glockner, F., and Ohm, T.G. (2006) Apolipoprotein E polymorphism and dendritic shape. , Neurobiology of Aging, 2006; 28(5): 693-703; discussion 704-6..
Teter, B., Finch, C.E.   Caliban’s Inheritance: Genetics of Neuronal Aging, Trends in Neuroscience , 2004; 10: 627-32.
Download
Teter B, Xu P-T, Gilbert JR, Roses AD, Galasko D, Cole GM   Defective neuronal sprouting supported by human Apolipoprotein E4 represents a gain-of-deleterious function, J. Neurosci. Res, 2002; (687): 331-336.
Download
Teter B, Ashford JW   Neuroplasticity in Alzheimer’s Disease, Journal of Neuroscience Research, 2002; 70(Aging Brain and Alzheimer’s Disease Special Issue): 402-437.
Download
Teter B, Raber J, Nathan B, Crutcher KA   The presence of apoE4, not the absence of apoE3, contributes to AD pathology, J. Alzheimer’s Disease, 2002; (4): 155-163.

David Teplow, Ph.D.

Biography

David Teplow received B.A. degrees in Biochemistry (1974) and in Bacteriology and Immunology (1975) at the University of California at Berkeley. He did graduate work in Tumor and Molecular Immunology at the University of Washington, where he received his M.S. (1977) and Ph.D. (1981) degrees. His graduate work, which involved protein chemical studies of cell surface receptors, led him to Caltech in Pasadena, where he worked first as a postdoctoral fellow and then as a junior faculty member to develop highly sensitive methods for protein primary structure analysis and to apply these new methods to the study of proteins in the nervous system. From 1991 through 2004, Dr. Teplow was a faculty member in the Departments of Neurology at Brigham and Women’s Hospital and Harvard Medical School, where he established a research program to understand the structural biology of the amyloid beta-protein (Abeta) and its contribution to the pathogenesis of Alzheimer’s disease (AD). Dr. Teplow joined the faculty at UCLA in 2005, where he currently is a Professor in Residence in the Department of Neurology, a member of the Molecular Biology Institute and the Brain Research Institute, the Director of the Biopolymer Laboratory at UCLA, and the Interim Director of Mary S. Easton Center for Alzheimer’s Disease Research at UCLA. Dr. Teplow is a leader in the areas of the structural biology of amyloid proteins and the biophysics of amyloid assembly. The Teplow laboratory seeks to understand and treat neurodegenerative disorders linked to pathologic protein folding. In AD, Abeta; self-associates to form a variety of oligomeric and polymeric structures with potent neurotoxic activities. Abeta; oligomers have been found in vivo in AD patients and may be the proximate neurotoxins in the disease. To understand how the nascent Abeta; monomer folds and assembles into neurotoxic forms, Dr. Teplow has employed an interdisciplinary strategy comprising in vivo, in vitro, in vacuo, and in silico approaches. The long-term goal is to discover the key factors controlling production of neurotoxic assemblies and then to target these factors in strategies for drug development. Dr. Teplow has published ~140 peer-reviewed articles, including ~100 original articles and ~40 reviews, book chapters, and commentaries. Dr. Teplow was a founding editorial board member of the Journal of Molecular Neuroscience and currently sits on the editorial boards of The Journal of Biological Chemistry, Amyloid: The Journal of Protein Folding Disorders, Current Chemical Biology, and The Yemeni Journal of Science.

Publications

A selected list of publications:

Takayuki Ohnishi, Masako Yanazawa1, Tomoya Sasahara, Yasuki Kitamura, Hidekazu Hiroaki, Yugo Fukazawa, Isao Kii, Takashi Nishiyama, Akiyoshi Kakita, Hiroyuki Takeda, Akihide Takeuchi, Yoshie Arai, Akane Ito, Hitomi Komura, Hajime Hirao, Kaori Satomura, Masafumi Inoue, Shin-ichi Muramatsu, Ko Matsui, Mari Tadag, Michio Sato, Eri Saijo, Yoshiki Shigemitsu, Satoko Sakai, Yoshitaka Umetsu, Natsuko Godd, Naomi Takino, Hitoshi Takahashi, Masatoshi Hagiwara, Tatsuya Sawasaki, Genji Iwasaki, Yu Nakamura, Yo-ichi Nabeshima, David B. Teplow, and Minako Hoshi   Na,K-ATPaseα3 Is a Death Target of Alzheimer Patient Amyloid-β Assembly PNAS, 2015; .
Thanh D. Do, Nichole E. LaPointe, Smriti Sangwan, David B. Teplow, Stuart C. Feinstein, Michael R. Sawaya, David S. Eisenberg, and Michael T. Bowers   Factors that drive peptide assembly from native to amyloid assembly:Experimental and theoretical analysis of [Leu-5]-enkephalin mutants J Phys Chem B, 2014; 188:7247-7256: .
Robin Roychaudhuri, Aleksey Lomakin, Summer Bernstein, Xueyun Zheng, Margaret M. Condron, George B. Benedek, Michael Bowers, and David B. Teplow   Gly25-Ser26 amyloid β-protein structural isomorphs produce distinct Aβ42 conformational dynamics and assembly characteristics J Mol Biol, 2014; 426:2422–2441: .
Do, Thanh; Economou, Nicholas; LaPointe, Nichole; Kincannon, William; Bleiholder, Christian; Feinstein, Stuart; Teplow, David; Buratto, Steven; Bowers, Michael   Factors That Drive Peptide Assembly and Fibril Formation: Experimental and Theoretical Analysis of Sup35 NNQQNY Mutants J Phys Chem B, 2013; 117:8436-46: .
Zhengjian Lv, Robin Roychaudhuri, Margaret M. Condron, David B. Teplow, Yuri L. Lyubchenko   Mechanism of amyloid β-protein dimerization determined using single-molecule AFM force spectroscopy Sci Rep, 2013; 3: doi:10.1038/srep02880.: .
Zhengjian Lv, Margaret M. Condron, David B. Teplow, and Yuri L. Lyubchenko   Nanoprobing of the effect of Cu2+ cations on misfolding, interaction and aggregation of amyloid β peptide J Neuroimmune Pharmacol, 2013; 8:262-273: .
Jun Wang, Mario G. Ferruzzi, Lap Ho, Jack Blount, Elsa M. Janle, Bing Gong, Yong Pan, G. A. Nagana Gowda, Daniel Raftery, Isabel Arrieta-Cruz, Vaishali Sharma, Bruce Cooper, Jessica Lobo, James E. Simon, Chungfen Zhang, Alice Cheng, Xianjuan Qian, Kenjiro Ono, David B. Teplow, Constantine Pavlides, Richard A. Dixon, and Giulio M. Pasinetti   Brain-Targeted Proanthocyanidin Metabolites for Alzheimer’s Disease Treatment J Neuroscience, 2012; (32): 5144-5150.
Hayden EY and Teplow DB   Continuous-flow reactor for production of stable amyloid protein oligomers Biochemistry, 2012; 51:6342-6349: .
L. Cruz, J. Srinivasa Rao, D. B. Teplow and B. Urbanc.   Dynamics of metastable β-hairpin structures in the folding nucleus of amyloid β-protein J Phys Chem B , 2012; 116:6311-6325: .
Gessel MM, Bernstein S, Kemper M, Teplow DB, Bowers MT   Familial Alzheimer’s disease mutations differentially alter amyloid β-protein oligomerization ACS Chem Neurosci, 2012; 3:909-918.: .
Ono K, Li L, Takamura Y, Yoshiike Y, Zhu L, Han F, Mao X, Ikeda T, Takasaki JI, Nishijo H, Takashima A, Teplow DB, Zagorski MG, Yamada M.   Phenolic compounds prevent amyloid β-protein oligomerization and synaptic dysfunction by site specific binding. J Biol Chem, 2012; 287:14631-14643.: .
Robin Roychaudhuri, Mingfeng Yang, Atul Deshpande, Gregory M. Cole, Sally Frautschy, Aleksey Lomakin, George B. Benedek, and David B. Teplow   C-terminal turn stability determines assembly differences between Aβ40 and Aβ42, J Mol Biol, in press, 2012; .
Roychaudhuri R, Condron MM, Lazo ND, and Teplow DB   Structural dynamics of the amyloid β-protein monomer folding nucleus. Biochem, in press, (This publication was highlighted on the journal’s home page), 2012; .
Ono K, Condron MM, and Teplow DB   Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid β-protein assembly and toxicity, JBC, 285:23186?23197, 2010; .
Urbanc B, Betnel M, Cruz L, Bitan G, Teplow DB   Elucidation of amyloid β-protein oligomerization mechanisms: Discrete molecular dynamics study, JACS, 132:4266?4280, 2010; .
Maji SK, Ogorzalek Loo RR, Spring SM, Vollers SS, Condron MM, Bitan G, Loo JA, and Teplow DB   Amino acid position-specific contributions to amyloid β-protein oligomerization, J Biol Chem, 284:23580?23591, 2009; .
Roychaudhuri R, Yang M, Hoshi MM, Teplow DB   Amyloid β-protein assembly and Alzheimer’s disease, J Biol Chem, 284:4749?4753, 2009; .
Ono K, Condron MM, Teplow DB   Structure-neurotoxicity relationships of amyloid β-protein oligomers, PNAS, 106:14745-14750, 2009; .
Ono K, Condron MM, Ho L, Wang J, Zhao W, Pasinetti GM, and Teplow DB   Effects of grape seed-derived polyphenols on amyloid β-protein self-assembly and cytotoxicity, J. Biol Chem, 283: 32176? 32187. (JBC ?Paper of the Week?), 2008; .
Grant MA, Lazo ND, Lomakin A, Condron MM, Arai H, Yamin G, Rigby AC, and Teplow DB   Familial Alzheimer’s disease mutations alter the stability of the amyloid β-protein monomer folding nucleus, PNAS, 104: 16522-16527, 2007; .
Maji SK, Amsden JJ, Rothschild KJ, Condron MM, Teplow DB   Conformational dynamics of Aβ assembly probed using intrinsic fluorescence, Biochemistry 44:13365-13376, 2005; .
Lazo ND, Grant MA, Condron MM, Rigby AC, Teplow DB   On the nucleation of amyloid β-protein monomer folding, Prot Sci, 14:1581-1596, 2005; .
Lazo ND, Grant MA, Condron MM, Rigby AC, Teplow DB   On the nucleation of amyloid β protein monomer folding, Prot Sci, 14:1581-1596, 2005; .
Bitan G, Tarus B, Vollers SS, Lashuel HA, Condron MM, Straub JE, Teplow DB   A molecular switch in amyloid assembly: Met35 and amyloid β-protein oligomerization, J Am Chem Soc, 50:15359-15365, 2003; .
Bitan G, Kirkitadze MD, Lomakin A, Vollers SS, Benedek GB, Teplow DB   Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways, Proc Natl Acad Sci USA, 100:330-335, 2003; .
Bitan G, Vollers SS, Teplow DB   Elucidation of primary structure elements controlling early amyloid β-protein oligomerization, J Biol Chem, 278:34882-34889, 2003; .
Bitan G, Lomakin A, Teplow DB   Amyloid β-protein oligomerization. Prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins, J Biol Chem, 276: 35176-35184, 2001; .
Kirkitadze MD, Condron MM, Teplow DB   Identification and characterization of key kinetic intermediates in amyloid β-protein fibrillogenesis, J Mol Biol 312:1103-1119, 2001; .
Walsh DM, Hartley DM, Fezoui Y, Condron MM, Lomakin A, Kusumoto Y, Benedek GB, Selkoe DJ, Teplow DB   Amyloid β-protein fibrillogenesis: Structure and biological activity of protofibrillar intermediates, J Biol Chem, 274:25945-25952, 1999; .
Walsh DM, Lomakin A, Benedek GB, Condron MM, Teplow DB   Amyloid β-protein fibrillogenesis: Detection of a protofibrillar intermediate, J Biol Chem. 272:22364-22372, 1997; .
Lomakin A, Chung DS, Benedek GB, Kirschner DA, Teplow DB   On the nucleation and growth of amyloid β-protein fibrils: Detection of nuclei and quantitation of rate constants, Proc Natl Acad Sci USA 93:1125-1129, 1996; .